|Slideshows|June 16, 2014

2014 Who's Who in Infection Prevention

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Copacabana Beach and Ipanema Beach in Rio de Janeiro, Brazil (Adobe Stock 193839900 by f11photo)

AIDS 2026: Malawi Targets the “Last Mile” of HIV Epidemic Control Through Community Care

ByTori Whitacre Martonicz, MA

August 14th 2026

AIDS 2026: Closing the Last-Mile Gap: Bringing HIV Care From Malawi’s Clinics Into Children’s Homes

ByTori Whitacre Martonicz, MA

August 13th 2026

Bug of the Month: You Never See Me Coming

ByTori Whitacre Martonicz, MA

August 12th 2026

Person washing hands. (Adobe Stock 200575602 By kieferpix)

From “Gotcha” to Coaching: Using RTLS to Improve Hand Hygiene

ByTori Whitacre Martonicz, MA

August 11th 2026

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants

ByTori Whitacre Martonicz, MA

August 10th 2026

Latest CME

Multimedia

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Onyema Ogbuagu, MD, FACP, FIDSA

2014 Who's Who in Infection Prevention

Related Content

AIDS 2026: Malawi Targets the “Last Mile” of HIV Epidemic Control Through Community Care

AIDS 2026: Closing the Last-Mile Gap: Bringing HIV Care From Malawi’s Clinics Into Children’s Homes

Bug of the Month: You Never See Me Coming

From “Gotcha” to Coaching: Using RTLS to Improve Hand Hygiene

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants

Latest CME

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Trending on Infection Control Today

AIDS 2026: Malawi Targets the “Last Mile” of HIV Epidemic Control Through Community Care

From “Gotcha” to Coaching: Using RTLS to Improve Hand Hygiene

Bug of the Month: You Never See Me Coming

AIDS 2026: Malawi Program Achieves 10-fold Reduction in HIV Positivity Among Exposed Infants

Global $17 Million Trial to Evaluate Phage Therapy for Drug-Resistant Recurrent UTIs